Ways, Belgium

Baptiste Manteau

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Baptiste Manteau: Pioneering Advances in Pharmacology

Introduction

Baptiste Manteau, an accomplished inventor based in Ways, Belgium, has made significant contributions to the field of pharmacology. His innovative work revolves around the discovery of compounds that could transform therapeutic practices, particularly in combating hyperproliferative and infectious diseases.

Latest Patents

Manteau holds a patent for "5-azaindazole derivatives as adenosine receptor antagonists." This invention addresses novel derivatives of the 5-azaindazole formula, providing a groundbreaking approach to creating effective dual A/Adenosine receptor antagonists. The patent includes not only these derivatives but also their pharmaceutically acceptable salts, solvates, prodrugs, and compositions, highlighting their potential therapeutic applications.

Career Highlights

Currently, Baptiste Manteau is associated with Merck Patent GmbH, where he continues to pursue his research and development endeavors. His commitment to enhancing medical treatments through innovative drug designs underscores his role as a key figure in modern pharmacology.

Collaborations

Manteau collaborates with talented colleagues, including Anne-Laure Blayo and Camille Amalric. Together, they work on advancing their research projects, nurturing a spirit of teamwork that fosters creativity and innovation in drug development.

Conclusion

Baptiste Manteau stands out as a promising inventor in the pharmaceutical sector, with his work paving the way for new and effective treatment options. His dedication to research and collaboration exemplifies the spirit of innovation in today's rapidly evolving healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…